A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies

Wei Jan Huang, Yen An Tang, Mei Yu Chen, Ying Jan Wang, Fu Han Hu, Tseng Wei Wang, Shi Wei Chao, Hui Wen Chiu, Ya Ling Yeh, Hsin Yi Chang, Hsueh Fen Juan, Pinpin Lin, Yi Ching Wang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Many histone deacetylase (HDAC) inhibitors show limited therapeutic effects for solid tumors. Here, we develop a novel HDAC inhibitor YCW1 and verify the combination effect of YCW1 and cisplatin in lung cancer pre-clinical models. YCW1 exerted cancer-specific cytotoxicity via mitochondria-mediated apoptosis. YCW1 and cisplatin showed synergistic anti-tumor effects through impairment of DNA damage repair. YCW1 inhibited tumor growth in lung orthotopic and subcutaneously implanted xenograft models. YCW1 significantly suppressed lung metastases via inhibition of focal adhesion complex. Our findings suggested that YCW1 is a potential HDAC inhibitor for lung cancer treatment as single and in combination regimens with cisplatin.

Original languageEnglish
Pages (from-to)84-93
Number of pages10
JournalCancer Letters
Volume346
Issue number1
DOIs
Publication statusPublished - Apr 28 2014

Fingerprint

Histone Deacetylase Inhibitors
Non-Small Cell Lung Carcinoma
Cisplatin
Lung Neoplasms
Neoplasms
Lung
Focal Adhesions
Therapeutic Uses
Heterografts
DNA Repair
DNA Damage
Mitochondria
Apoptosis
Neoplasm Metastasis
Growth

Keywords

  • Apoptosis
  • Cisplatin
  • Histone deacetylase inhibitor
  • Metastasis
  • Non-small cell lung cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies. / Huang, Wei Jan; Tang, Yen An; Chen, Mei Yu; Wang, Ying Jan; Hu, Fu Han; Wang, Tseng Wei; Chao, Shi Wei; Chiu, Hui Wen; Yeh, Ya Ling; Chang, Hsin Yi; Juan, Hsueh Fen; Lin, Pinpin; Wang, Yi Ching.

In: Cancer Letters, Vol. 346, No. 1, 28.04.2014, p. 84-93.

Research output: Contribution to journalArticle

Huang, Wei Jan ; Tang, Yen An ; Chen, Mei Yu ; Wang, Ying Jan ; Hu, Fu Han ; Wang, Tseng Wei ; Chao, Shi Wei ; Chiu, Hui Wen ; Yeh, Ya Ling ; Chang, Hsin Yi ; Juan, Hsueh Fen ; Lin, Pinpin ; Wang, Yi Ching. / A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies. In: Cancer Letters. 2014 ; Vol. 346, No. 1. pp. 84-93.
@article{d611c59d8007408089ef9252f323a67a,
title = "A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies",
abstract = "Many histone deacetylase (HDAC) inhibitors show limited therapeutic effects for solid tumors. Here, we develop a novel HDAC inhibitor YCW1 and verify the combination effect of YCW1 and cisplatin in lung cancer pre-clinical models. YCW1 exerted cancer-specific cytotoxicity via mitochondria-mediated apoptosis. YCW1 and cisplatin showed synergistic anti-tumor effects through impairment of DNA damage repair. YCW1 inhibited tumor growth in lung orthotopic and subcutaneously implanted xenograft models. YCW1 significantly suppressed lung metastases via inhibition of focal adhesion complex. Our findings suggested that YCW1 is a potential HDAC inhibitor for lung cancer treatment as single and in combination regimens with cisplatin.",
keywords = "Apoptosis, Cisplatin, Histone deacetylase inhibitor, Metastasis, Non-small cell lung cancer",
author = "Huang, {Wei Jan} and Tang, {Yen An} and Chen, {Mei Yu} and Wang, {Ying Jan} and Hu, {Fu Han} and Wang, {Tseng Wei} and Chao, {Shi Wei} and Chiu, {Hui Wen} and Yeh, {Ya Ling} and Chang, {Hsin Yi} and Juan, {Hsueh Fen} and Pinpin Lin and Wang, {Yi Ching}",
year = "2014",
month = "4",
day = "28",
doi = "10.1016/j.canlet.2013.12.016",
language = "English",
volume = "346",
pages = "84--93",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies

AU - Huang, Wei Jan

AU - Tang, Yen An

AU - Chen, Mei Yu

AU - Wang, Ying Jan

AU - Hu, Fu Han

AU - Wang, Tseng Wei

AU - Chao, Shi Wei

AU - Chiu, Hui Wen

AU - Yeh, Ya Ling

AU - Chang, Hsin Yi

AU - Juan, Hsueh Fen

AU - Lin, Pinpin

AU - Wang, Yi Ching

PY - 2014/4/28

Y1 - 2014/4/28

N2 - Many histone deacetylase (HDAC) inhibitors show limited therapeutic effects for solid tumors. Here, we develop a novel HDAC inhibitor YCW1 and verify the combination effect of YCW1 and cisplatin in lung cancer pre-clinical models. YCW1 exerted cancer-specific cytotoxicity via mitochondria-mediated apoptosis. YCW1 and cisplatin showed synergistic anti-tumor effects through impairment of DNA damage repair. YCW1 inhibited tumor growth in lung orthotopic and subcutaneously implanted xenograft models. YCW1 significantly suppressed lung metastases via inhibition of focal adhesion complex. Our findings suggested that YCW1 is a potential HDAC inhibitor for lung cancer treatment as single and in combination regimens with cisplatin.

AB - Many histone deacetylase (HDAC) inhibitors show limited therapeutic effects for solid tumors. Here, we develop a novel HDAC inhibitor YCW1 and verify the combination effect of YCW1 and cisplatin in lung cancer pre-clinical models. YCW1 exerted cancer-specific cytotoxicity via mitochondria-mediated apoptosis. YCW1 and cisplatin showed synergistic anti-tumor effects through impairment of DNA damage repair. YCW1 inhibited tumor growth in lung orthotopic and subcutaneously implanted xenograft models. YCW1 significantly suppressed lung metastases via inhibition of focal adhesion complex. Our findings suggested that YCW1 is a potential HDAC inhibitor for lung cancer treatment as single and in combination regimens with cisplatin.

KW - Apoptosis

KW - Cisplatin

KW - Histone deacetylase inhibitor

KW - Metastasis

KW - Non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=84896724651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896724651&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2013.12.016

DO - 10.1016/j.canlet.2013.12.016

M3 - Article

C2 - 24355296

AN - SCOPUS:84896724651

VL - 346

SP - 84

EP - 93

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -